**Core Concept**
The rejection phenomenon after kidney transplant is an immune response where the recipient's immune system recognizes the transplanted kidney as foreign and mounts an attack against it. The primary target for this early immunological attack is the endothelial cells lining the blood vessels of the transplanted kidney, which express human leukocyte antigen (HLA) class I and II molecules.

**Why the Correct Answer is Right**
The endothelial cells expressing HLA class I and II molecules are recognized as foreign by the recipient's immune system, triggering an immune response. The immune cells, including T cells and macrophages, bind to these HLA molecules and initiate an inflammatory response, leading to the rejection of the transplanted kidney. This process is mediated by the activation of complement system and the production of cytokines such as TNF-alpha and IL-1 beta.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because the epithelial cells lining the renal tubules are not the primary target for early immunological attack. While they may be involved in the rejection process, they are not the initial target.
* **Option B:** This option is incorrect because the mesangial cells in the glomerulus are not the primary target for early immunological attack. They may be affected in the later stages of rejection but are not the initial target.
* **Option C:** This option is incorrect because the podocytes are not the primary target for early immunological attack. They may be affected in the later stages of rejection but are not the initial target.

**Clinical Pearl / High-Yield Fact**
In kidney transplant rejection, the endothelial cells expressing HLA class I and II molecules are the primary target for early immunological attack, leading to inflammation and immune cell activation. The use of immunosuppressive drugs such as cyclosporine and tacrolimus can help prevent this rejection by inhibiting T cell activation and reducing the production of cytokines.

**Correct Answer:** C.